WallStreetZenWallStreetZen

NASDAQ: MOLN
Molecular Partners Ag Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MOLN

Based on 1 analyst offering 12 month price targets for Molecular Partners Ag

Min Forecast
$4.00+6.1%
Avg Forecast
$4.00+6.1%
Max Forecast
$4.00+6.1%

Should I buy or sell MOLN stock?

Based on 1 analyst offering ratings for Molecular Partners Ag.

Hold
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 100%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their MOLN stock forecasts and price targets.

MOLN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-03

1 of 1

Forecast return on equity

Is MOLN forecast to generate an efficient return?

Company
-87.6%
Industry
252.89%
Market
145.2%
MOLN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MOLN forecast to generate an efficient return on assets?

Company
-75.2%
Industry
107.15%
MOLN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MOLN earnings per share forecast

What is MOLN's earnings per share in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$1.52
Avg 2 year Forecast
-$1.27
Avg 3 year Forecast
-$0.62

MOLN revenue forecast

What is MOLN's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$1.0M+22.82%
Avg 2 year Forecast
$11.2M+1,251.01%
Avg 3 year Forecast
$48.5M+5,733.93%
MOLN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MOLN revenue growth forecast

How is MOLN forecast to perform vs Biotechnology companies and vs the US market?

Company
273.89%
Industry
107.72%
Market
25.08%
MOLN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MOLN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MOLN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MOLN$3.77$4.00+6.10%Hold
MCRB$15.78$14.00-11.28%Buy
ACTU$6.58$20.00+203.95%Strong Buy
CLYM$1.99$9.00+352.26%Strong Buy
ABOS$2.22$9.00+305.41%Strong Buy
View Top Biotech Stocks

Molecular Partners Ag Stock Forecast FAQ

Is Molecular Partners Ag Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MOLN) stock is to Hold MOLN stock.

Out of 1 analyst, 0 (0%) are recommending MOLN as a Strong Buy, 0 (0%) are recommending MOLN as a Buy, 1 (100%) are recommending MOLN as a Hold, 0 (0%) are recommending MOLN as a Sell, and 0 (0%) are recommending MOLN as a Strong Sell.

If you're new to stock investing, here's how to buy Molecular Partners Ag stock.

What is MOLN's earnings growth forecast for 2025-2027?

(NASDAQ: MOLN) Molecular Partners Ag's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 25.97%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41.35%.

Molecular Partners Ag's earnings in 2025 is -$80,003,703.On average, 4 Wall Street analysts forecast MOLN's earnings for 2025 to be -$56,828,901, with the lowest MOLN earnings forecast at -$58,631,213, and the highest MOLN earnings forecast at -$54,181,522. On average, 4 Wall Street analysts forecast MOLN's earnings for 2026 to be -$47,484,552, with the lowest MOLN earnings forecast at -$69,624,565, and the highest MOLN earnings forecast at -$23,164,564.

In 2027, MOLN is forecast to generate -$23,074,822 in earnings, with the lowest earnings forecast at -$86,114,594 and the highest earnings forecast at $44,758,649.

What is MOLN's revenue growth forecast for 2025-2027?

(NASDAQ: MOLN) Molecular Partners Ag's forecast annual revenue growth rate of 273.89% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 107.72%, and it is also forecast to beat the US market's average forecast revenue growth rate of 25.08%.

Molecular Partners Ag's revenue in 2025 is $840,740.On average, 4 Wall Street analysts forecast MOLN's revenue for 2025 to be $38,140,202, with the lowest MOLN revenue forecast at $0, and the highest MOLN revenue forecast at $78,523,946. On average, 4 Wall Street analysts forecast MOLN's revenue for 2026 to be $419,542,223, with the lowest MOLN revenue forecast at $0, and the highest MOLN revenue forecast at $863,763,401.

In 2027, MOLN is forecast to generate $1,811,659,600 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $3,729,887,411.

What is MOLN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: MOLN) forecast ROA is -75.2%, which is lower than the forecast US Biotechnology industry average of 107.15%.

What is MOLN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MOLN price target, the average MOLN price target is $4.00, with the highest MOLN stock price forecast at $4.00 and the lowest MOLN stock price forecast at $4.00.

The Wall Street analyst predicted that Molecular Partners Ag's share price could reach $4.00 by Sep 3, 2026. The average Molecular Partners Ag stock price prediction forecasts a potential upside of 6.1% from the current MOLN share price of $3.77.

What is MOLN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: MOLN) Molecular Partners Ag's current Earnings Per Share (EPS) is -$2.21. On average, analysts forecast that MOLN's EPS will be -$1.52 for 2025, with the lowest EPS forecast at -$1.57, and the highest EPS forecast at -$1.45. On average, analysts forecast that MOLN's EPS will be -$1.27 for 2026, with the lowest EPS forecast at -$1.86, and the highest EPS forecast at -$0.62. In 2027, MOLN's EPS is forecast to hit -$0.62 (min: -$2.30, max: $1.20).

What is MOLN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: MOLN) forecast ROE is -87.6%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.